Treatment of tinea capitis - A critical appraisal;Die Behandlung der Tinea capitis ? Eine kritische Bestandsaufnahme

JDDG - Journal of the German Society of Dermatology

Volumn 9, Issue 2, 2011, Pages 109-114

  Ginter Hanselmayer, Gabriele ^a   Seebacher, Claus ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b NONE   (Germany)

Author keywords

Fluconazole; Griseofulvin; Itraconazole; Terbinafine; Tinea capitis

Indexed keywords

AMISAN; BIOCAN M PLUS; BIOFEL M PLUS; CICLOPIROXOLAMINE; FLUCONAZOLE; FUNGUS ANTIGEN; GRISEOFULVIN; INACTIVATED VACCINE; ITRACONAZOLE; KERATIN; MICROSPORUM CANIS ANTIGEN; PLACEBO; POVIDONE IODINE; SELENIUM SULFIDE; SHAMPOO; TERBINAFINE; UNCLASSIFIED DRUG;

CHILDHOOD DISEASE; COMPETITIVE INHIBITION; CONIDIUM; DRUG CAPSULE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG PULSE THERAPY; GOLD STANDARD; HAIR FOLLICLE; HAIR GROWTH; HUMAN; MICROSPOROSIS; MICROSPORUM; MICROSPORUM CANIS; PUBERTY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; REVIEW; SCALP; SEBUM SECRETION; SWEAT; TINEA CAPITIS; TOPICAL TREATMENT; TREATMENT DURATION; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; UNITED STATES; UNSPECIFIED SIDE EFFECT;

EID: 79751519626     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2010.07554.x     Document Type: Review

References (42)

1. Aly R,. Ecology, epidemiology and diagnosis of tinea capitis. Pediatr Infect Dis J 1999; 18: 180-185. (Pubitemid 29101901)
2. Seebacher C, Bouchara J-P, Mignon B,. Updates on epidemiology of dermato-phyte infections. Mycopathologia 2008; 166: 335-352.
3. Wildfeuer A, Faergemann J, Laufen H, Pfaff G, Zimmermann T, Seidl HP, Lach P,. Bioavailability of fluconazole in the skin after oral medication. Mycoses 1994; 37: 127-130. (Pubitemid 24316049)
4. Shah P, Epstein WL, Riegelman S,. Role of sweat in accumulation of orally administered griseofulvin in skin. J Clin Invest 1974; 53: 1673-1678.
5. Faergemann J, Zehender H, Milleroux L,. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin Exp Dermatol 1994; 19: 121-126. (Pubitemid 24216583)
6. Cauwenberg G, Degreef H, Heykants J, Woestenborghs R, Van Rooy P, Haeverans K,. Pharmakokinetic profile of orally administerd itraconazole in human skin. J Am Acad Dermatol 1988; 18: 263-268. (Pubitemid 18061192)
7. Seebacher C,. Grenzen der Kurzzeitbe-handlung von Onychomykosen. Hautarzt 1998; 49: 705-708.
8. Götz H,. Die Pilzkrankheiten der Haut durch Dermatophyten. In:, Marcionini A, Götz H,: Handbuch der Haut- und Geschlechtskrankheiten, Ergänzungs-werk, Bd IV, Teil 3. Berlin Göttingen Heidelberg: Springer, 1962; 234-240, 382- 385.
9. Lukacs A, Korting HC, Lindner A,. Successful treatment of griseofulvin-resistant tinea capitis in infants. Mycoses 1994; 37: 451-453.
10. Almeida SR,. Immunology of Dermatophytosis. Mycopathologia 2008; 166: 277-283.
11. Lund A, DeBoer DJ,. Immunprophylaxis of dermatophytosis in animals. Mycopathologia 2008; 166: 407-424.
12. Blaschke-Hellmessen R, Haufe U, Seebacher C,. Statistischer Bericht über die Dermatophytenflora bei Derma-tomykosen in der DDR von 1967 bis 1971. Dermatol Monschr 1975; 161: 433-449.
13. Elsner P, Hartmann AA, Kohlbeck M,. Dermatophytoses in Würzburg 1976-1985. Mycoses 1995; 30: 584-588.
14. Rieth H,. Griseofulvin bei der Mikros-porie und der Trichophytie. In:, Götz H,: Die Griseofulvinbehandlung der Der-matomykosen. Berlin Göttingen Heidelberg: Springer, 1962: 40-52.
15. Götz H,. Die Behandlung des Favus mit Griseofulvin. In:, Götz H,: Die Griseofulvinbehandlung der Dermatomykosen. Berlin Göttingen Heidelberg: Springer, 1962: 35-40.
16. Aste N, Pau M, Biggio P,. Tinea capitis in children in the district of Cagliari, Italy. Mycoses 1997; 40: 231-233. (Pubitemid 28018499)
17. Fachinformation (Zusammenfassung der Merkmale des Arzneimittels) Griseo-CT Tabletten. März 2007.
18. Chen B, Friedlander S,. Tinea capitis update: A continuing conflict with an old adversary. Current Opinion in Pediatrics, 2001; 13: 331-335. (Pubitemid 32701862)
19. Seebacher C, Abeck D, Brasch J, Cornely O, Daeschlein G, Effendy I, Ginter-Hanselmayer G, Haake N, Hamm G, Hipler U-Ch, Hof H, Korting H Ch, Kramer A, Mayser P, Ruhnke M, Schlacke K-H, Tietz J,. Leitlinie Tinea capitis. JDDG 2006; 12: 1085-1092.
20. Roberts BJ, Friedlander SF,. Tinea capitis: a treatment update. Pediatric Ann 2005; 34: 191-200. (Pubitemid 40396165)
21. Dasghaib L, Azizzadeh M, Jafari P,. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole. J Dermatol Treatm 2005; 16: 43-46. (Pubitemid 40283324)
22. Mikki M-O,. Tinea capitis: diagnostic criteria and treatment options. Pediatric Nursing 2009; 35: SS-SS
23. Gupta AK, Nolting S, de Prost Y, Delescluse J, Degreef H, Theissen U, Wallace R, Marynissen G,: The use of itraconazole to treat cutaneous fungal infections in children. Dermatology 1999; 248: 248-252.
24. Möhrenschlager M, Seidl HP, Ginter-Hanselmayer G, Abeck D,. Tinea capitis of childhood: incidence and pathoge-netic role of Trichophyton tonsurans in Central Europe. J Am Acad Dermatol 2001; 45: 320.
25. Lõpez-Gõmez S, Del Palazio A,. Itraco-nazole versus Griseofulvin in the treatment of tinea capitis: A double-blind randomized study in children. Int J Dermatol 1994; 33: 743-747. (Pubitemid 24321786)
26. Ginter-Hanselmayer, G., Smolle, J., Gupta, A., Itraconazole in the Treatment of Tinea Capitis Caused by Microsporum canis: Experience in a Large Cohort. Pediatric Dermatology 2004; 21 (4): 499-502. (Pubitemid 39050631)
27. Binder B, Richtig E, Weger W, Ginter-Hanselmayer G,. Tinea capitis in early infancy treated with itraconazole: a pilot study. JEADV 2009; 23 (10): 1161-1163.
28. Higgins, E M, Fuller, L C, Smith C H,. Guidelines for management of tinea capitis. Br J Dermatol 2000; 143: 53-58.
29. Hamm H, Schwinn A, Bräutigam M, Weidinger G, Study Group. Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. Br J Dermatol 1999; 140: 480-482. (Pubitemid 29182881)
30. Friedlander SF, Aly R, Krafchik B, Blumer J, Honig P, Stewart D, Lucky AW, Gupta AK, Babel DE, Abrams B, Gourmala N, Wraith LA, Paul C, and Tinea Capitis Study Group. Terbinafine in the treatment of Trichophyton tinea capitis: A randomized, double-blind, parallel-group, duration-finding study. Pediatrics 2002; 109: 602-607. (Pubitemid 34286292)
31. Friedlander SF,. Treating tinea capitis with Terbinafine: latest findings. JEADV 2001; 15 (Suppl 2) 99 (Abstract).
32. Elewski BE, Caceres HW, DeLeon L, El Shimy S, Hunter JA, Korotkly N, Rachesky IJ, Sanchez-Bal V, Todd G, Wraith L, Cai B, Tavakkol A, Bakshi R, Nyirady J, Friedlander SF,. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: Results of two randomized, investigator-blinded, multicenter, international, controlled trials, J Am Acad Dermatol 2008; 59: 41-54.
33. Deglin, JH, Vallerand AH,. Davis drug guide for nurses (11th ed.). Philadelphia: F.A. Davis Company, 2009.
34. Ghannoum MA, Wraith LA, Cai B, Nyirady J, Isham N,. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial. Br J Dermatol 2008; 159: 711-713.
35. Foster KW, Friedlander SF, Panzer H, Ghannoum MA, Elewski BE,. A randomized controlled assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis. J Am Acad Dermatol 2005; 53: 798-809. (Pubitemid 41501365)
36. Gupta AK, Dlova N, Taborda P, Morar N, Taborda V, Lynde CW, Konnikov N, Borges M, Raboobee N, Summerbell RC, Adam P, Hofstader SLR, Aboo-baker J,. Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicenter study. Bt J Dermatol 2000; 142: 965-968. (Pubitemid 30304609)
37. Gupta AK, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, Aboobaker J, Summerbell RC,. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: Gri-seofulvin versus the new oral antifungal Agents, Terbinafine, Itraconazole, and Fluconazole. Pediatr Dermatol 2001; 18: 433-438. (Pubitemid 33070714)
38. Gupta AK, Ahmadi L, Summerbell RC,. Comparative efficacies of commonly disinfectants and antifungal pharmaceutical spray preparations against dermatophytic fungi. Med Mycol 2001; 39: 321-328. (Pubitemid 32791481)
39. Karelson M, Pärna E, Slim H, Majass M, Rajangu H,. Pilot study of Lamisil in the treatment of tinea capitis in Microsporum canis infected prepubertal children. J Eur Acad Dermatol Venereol 1995; 5 (Suppl 1): S172.
40. Hänel H, Abrams B, Dittmar W, Ehlers G,. A comparison of bifonazole and ciclopiroxolamine: in vitro, animal, and clinical studies. Mycoses 1988; 31: 632-64.
41. Seebacher C,. Action mechanisms of modern antifungal agents and the resulting problems in the management of ony-chomycosis. Mycoses 2003; 46: 506-510. (Pubitemid 38005348)
42. Kurdak H, Sezer T, Ilkit M, Ates A, Bozdemir N,. Scalp dermatophyte carriage in a day care center survey in Turkey. Mycopathologia 2009; 167: 139-133.